Revenue ($USD) : $2,633,995,423
Revenue (foreign currencies) : DKK kr18,645,000,000
R&D spend : not available
Employees : not available
Fiscal year end : 12/31/22
CEO : Søren Nielsen

Healthcare and audio technology company Demant’s history stretches back to 1904. Demant provides hearing aids, hearing implants and diagnostic equipment and services to hearing care professionals and users in more than 130 countries. The majority of Demant A/S shares are held by the William Demant Foundation and are listed on Nasdaq Copenhagen as a blue-chip stock. –CN